Annual ROE
617.96%
+1199.71%+206.22%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual return on equity is 617.96%, with the most recent change of +1199.71% (+206.22%) on December 31, 2023.
- During the last 3 years, EFTR annual ROE has risen by +628.71% (+5848.47%).
- EFTR annual ROE is now at all-time high.
Performance
EFTR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
2178.39%
+984.59%+82.48%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly return on equity is 2178.39%, with the most recent change of +984.59% (+82.48%) on March 31, 2024.
- Over the past year, EFTR quarterly ROE has increased by +2650.84% (+561.08%).
- EFTR quarterly ROE is now -65.03% below its all-time high of 6228.94%, reached on September 30, 2023.
Performance
EFTR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
EFTR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +206.2% | +561.1% |
| 3 y3 years | +5848.5% | +561.1% |
| 5 y5 years | +5848.5% | +561.1% |
EFTR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +206.2% | -65.0% | +293.5% |
| 5 y | 5-year | at high | +206.2% | -65.0% | +293.5% |
| alltime | all time | at high | +206.2% | -65.0% | +293.5% |
EFFECTOR Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | 2178.39%(+82.5%) |
| Dec 2023 | 617.96%(-206.2%) | 1193.80%(-80.8%) |
| Sep 2023 | - | 6228.94%(-653.4%) |
| Jun 2023 | - | -1125.65%(+138.3%) |
| Mar 2023 | - | -472.45%(+214.3%) |
| Dec 2022 | -581.75% | -150.32%(-590.8%) |
| Sep 2022 | - | 30.63%(-82.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | 176.84%(-19.3%) |
| Mar 2022 | - | 219.08%(-33.3%) |
| Dec 2021 | 91.40%(-950.2%) | 328.61%(+2423.9%) |
| Sep 2021 | - | 13.02%(-32.7%) |
| Jun 2021 | - | 19.35%(+27.6%) |
| Mar 2021 | - | 15.16%(+48.9%) |
| Dec 2020 | -10.75% | 10.18% |
FAQ
- What is eFFECTOR Therapeutics annual return on equity?
- What is the all time high annual ROE for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual ROE year-on-year change?
- What is eFFECTOR Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly ROE year-on-year change?
What is eFFECTOR Therapeutics annual return on equity?
The current annual ROE of EFTR is 617.96%
What is the all time high annual ROE for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual return on equity is 617.96%
What is eFFECTOR Therapeutics annual ROE year-on-year change?
Over the past year, EFTR annual return on equity has changed by +1199.71% (+206.22%)
What is eFFECTOR Therapeutics quarterly return on equity?
The current quarterly ROE of EFTR is 2178.39%
What is the all time high quarterly ROE for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly return on equity is 6228.94%
What is eFFECTOR Therapeutics quarterly ROE year-on-year change?
Over the past year, EFTR quarterly return on equity has changed by +2650.84% (+561.08%)